المؤلفون: Bhavesh Lakhotia, Praveen Thokala, Florian S. Gutzwiller, Ivan Nikolaev, Andriy Danyliv, Ronan Mahon

المصدر: International Journal of Chronic Obstructive Pulmonary Disease. 15:787-797

مصطلحات موضوعية: COPD, medicine.medical_specialty, Exacerbation, Markov chain, Cost effectiveness, business.industry, General Medicine, Markov model, medicine.disease, respiratory tract diseases, 03 medical and health sciences, 0302 clinical medicine, 030228 respiratory system, medicine, Indacaterol, 030212 general & internal medicine, Salmeterol, business, Intensive care medicine, health care economics and organizations, medicine.drug, Fluticasone

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::007c537140bb5d099fe9962909adb2ddTest
https://doi.org/10.2147/copd.s247156Test

المؤلفون: Madlaina Costa-Scharplatz, Thys van der Molen, Karin Lisspers, Ronan Mahon, Colin Burke, Leif Bjermer, Job F M van Boven, Florian S. Gutzwiller, Nicolas Roche, Petter Olsson

المساهمون: Groningen Research Institute for Asthma and COPD (GRIAC), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Value, Affordability and Sustainability (VALUE)

المصدر: European Respiratory Journal, 50. EUROPEAN RESPIRATORY SOC JOURNALS LTD

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, animal structures, Salmeterol fluticasone, Exacerbation, Copd patients, business.industry, Population, Pulmonary disease, Indirect costs, Internal medicine, medicine, Indacaterol, education, business, health care economics and organizations, medicine.drug, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::517cb6fc2d65031513ff1f93f2e72b58Test
https://hdl.handle.net/11370/d0a20528-f4bc-4754-84a9-2dfb2e8d5934Test

المؤلفون: Ronan Mahon, Dorothy L. Keininger, Job F M van Boven, Nicolas Roche, Leif Bjermer, Florian S. Gutzwiller, Madlaina Costa-Scharplatz, Karin Lisspers, Petter Olsson

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Value, Affordability and Sustainability (VALUE), Groningen Research Institute for Asthma and COPD (GRIAC)

المصدر: Respiratory Research
Respiratory Research, 18:206. BioMed Central Ltd.
Respiratory Research, Vol 18, Iss 1, Pp 1-10 (2017)

مصطلحات موضوعية: Male, Exacerbation, Salmeterol fluticasone, Respiratory Medicine and Allergy, Cost-Benefit Analysis, INHALED CORTICOSTEROIDS, Quinolones, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Medicine, 030212 general & internal medicine, health care economics and organizations, Lungmedicin och allergi, Fluticasone, RISK, COPD, Chronic obstructive pulmonary disease, Middle Aged, Fluticasone-Salmeterol Drug Combination, Drug Combinations, Models, Economic, Population Surveillance, Indans, Female, Salmeterol, medicine.drug, Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi, medicine.medical_specialty, animal structures, Pulmonary disease, OBSTRUCTIVE PULMONARY-DISEASE, SALMETEROL-FLUTICASONE, 03 medical and health sciences, Swedish population, Double-Blind Method, Internal medicine, Humans, COMBINATION, Indacaterol/glycopyrronium, Aged, lcsh:RC705-779, Sweden, business.industry, Research, QVA149, Health Care Service and Management, Health Policy and Services and Health Economy, lcsh:Diseases of the respiratory system, Cost-effective, medicine.disease, Glycopyrrolate, SEVERITY, 030228 respiratory system, Indacaterol, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2990a6505beb73864bba0a826bd42fdcTest
https://pubmed.ncbi.nlm.nih.gov/29228950Test